Mass spectrometry has become one of the most important tools in the biochemical sciences widely used to accurately identify molecules, such as defective proteins, that underline diseases. By detecting and identifying these molecules, scientists are better able to discover cures for diseases, minimize the response time for bacterial and viral outbreaks, improve clinical diagnostics, optimize drug safety, and provide greater individualized health care. Significant progress has been made in identifying small mass molecules. Unfortunately, the industry has not developed a technology that consistently identifies large mass molecules. As a result, scientists are using limited information leading, incomplete diagnosis, as well as inefficient drug quality assurance, and treatment becomes less precise.
In 2008, ProsperoBiosciences developed a high mass protein detector to characterize and identify proteins in the field of mass spectrometry based on nanotechnology. This improves the analytical method by a factor of 30, as compared to what is currently available in the market. All of this with unprecedented resolution. This means more complete and accurate information, more precise identification, and ultimately, more effective treatments.